Search for Resources
Back to previous page
Back to previous page

Management of Denosumab Cessation

Introduction:

Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS

Resource:

Flowchart not shown here for copyright reasons. Please click on link below for management flowchart

Link:

Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic (oup.com)

Related Information:

Reference:

Elena Tsourdi, M Carola Zillikens, Christian Meier, Jean-Jacques Body, Elena Gonzalez Rodriguez, Athanasios D Anastasilakis, Bo Abrahamsen, Eugene McCloskey, Lorenz C Hofbauer, Nuria Guañabens, Barbara Obermayer-Pietsch, Stuart H Ralston, Richard Eastell, Jessica Pepe, Andrea Palermo, Bente Langdahl, Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS, The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 1, January 2021, Pages 264–281